Page 4 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Lilly to buy injectable drug plant in manufacturing ramp-up

Published: April 23, 2024

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesNorth CarolinaPleasant PrairieNovo NordiskDrug AdministrationAnexus PharmaceuticalsNovo HoldingsDive BriefBiopharma DiveUmer Raffat

Novartis pauses some trials of cancer drug Kisqali to fix manufacturing

Published: April 10, 2024

BioPharma

Source: biopharmadive.com

Related Topics:

Eli Lilly VerzenioEli LillyDrug AdministrationDive BriefUmer RaffatClinical Trials

Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2023 Earnings Call Transcript

Published: February 28, 2024

Operator: Good morning, my name is Krista and I’ll be your conference Operator today.

Source: insidermonkey.com

Related Topics:

United StatesGlen SantangeloJeff SimmonsCredelio QuattroTodd YoungBalaji PrasadKatie GrissomChris SchottMichael RyskinScott PuruckerErin WrightKaty GrissomElanco Animal Health IncMorgan StanleyElanco Animal Health IncorporatedJp MorganMerck Animal HealthElanco Animal HealthCall Transcript FebruaryAnimal Health IncorporatedChief Executive OfficerChief Financial OfficerInvestor RelationsRisk FactorsCredelio Plus

Bausch Health Companies Inc. (NYSE:BHC) Q4 2023 Earnings Call Transcript

Published: February 23, 2024

Bausch Health Companies Inc. beats earnings expectations. Reported EPS is $1.15, expectations were $1.01.

Source: insidermonkey.com

Related Topics:

United StatesMaria LikurisJohn BarresiGlen SantangeloPiper SandlerAsia PacificBausch LombThomas AppioDavid AmsellemDelaware District CourtBausch Health Companies IncSolta MedicalNational Medical Products AdministrationDistrict CourtBausch HealthUs CourtDc District CourtBausch Health Investor RelationsBausch Health CompaniesCall Transcript FebruaryHealth CompaniesChief Executive OfficerChief FinancialInvestor RelationsFor Bausch Health

Biogen Inc. (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript

Published: February 14, 2024

Biogen Inc. beats earnings expectations. Reported EPS is $3.3, expectations were $3.16. Biogen Inc.

Source: insidermonkey.com

Related Topics:

United StatesChuck TrianoSalveen RichterChris ViehbacherPaul MattiasAdam KeeneyMike McdonnellMarc GoodmanEvan SeigermanPriya SinghalBiogen IncGoldman SachsHead Of Corporate DevelopmentEuropean CommissionEuropean UnionHead Of DevelopmentCall Transcript FebruaryBiogen Fourth QuarterChief Executive OfficerInflation Reduction ActSystemic Lupus ErythematosusCutaneous Lupus ErythematosusCorporate DevelopmentReliable Cars For SeniorsMedicare Advantage